✨ Free AI Report
DermTech, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research DermTech, Inc.
Company Research

DermTech, Inc.: Business Overview, Financials & Competitive Analysis

DermTech, Inc. was a precision dermatology company that developed non-invasive skin genomics diagnostic products, including melanoma screening tests delivered via smart stickers. The company filed for Chapter 11 bankr...

Analyst-debate audio for DermTech, Inc.

AskCyborg analysts argue the bull and bear cases for DermTech, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
1/ 10Challenged

Cyborg Score thesis

DermTech is insolvent and no longer a viable investment vehicle—the company has exited the...

Read the full analyst-debate transcript →
Industry Diagnostic Laboratories
1 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 9, 2026
AI-Generated Research
30+ Page Report

Get the Latest DermTech, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

DermTech, Inc. Overview

Pro stress-test →

DermTech, Inc. was a precision dermatology company that developed non-invasive skin genomics diagnostic products, including melanoma screening tests delivered via smart stickers. The company filed for Chapter 11 bankruptcy liquidation in August 2025 and is no longer operationally active.

Strategic Profile

Pro stress-test →

The company focused on transforming dermatology diagnostics through molecular testing rather than traditional biopsy methods. Operations ceased following the bankruptcy filing, and the company now exists in liquidation status with its stock trading on OTC markets.

Competitive Landscape

Pro stress-test →

Prior to bankruptcy, DermTech competed with other skin cancer diagnostic platforms and dermatology testing companies. The competitive landscape included traditional biopsy methods and emerging genomic testing alternatives.

Industry Context

DermTech, Inc. operates in Diagnostic Laboratories.

Key facts

Founded: 2007 · Headquarters: La Jolla, US · Employees: N/A · Revenue: N/A · Market cap: N/A

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on DermTech, Inc..

  • Filed Chapter 11 bankruptcy liquidation in August 2025
  • Stock now trades OTC (DMTKQ) at penny stock prices ($0.01)
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • August 2025Filed Chapter 11 liquidation bankruptcy
  • Stock delisted from NASDAQ and now trades OTC
Get alerted when DermTech, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Strata Skin SciencesDermatology diagnostics and treatments→

Compare DermTech, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

DermTech, Inc. operates in Diagnostic Laboratories. See how the rest of the sector scores on the Cyborg framework.

Browse Diagnostic Laboratories research →
NEW · MCP server

Ask your AI assistant about DermTech, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare DermTech, Inc. and its top competitor on Cyborg Score”
“What did DermTech, Inc. do this quarter?”
“Is DermTech, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does DermTech, Inc. do?+
DermTech, Inc. was a precision dermatology company that developed non-invasive skin genomics diagnostic products, including melanoma screening tests delivered via smart stickers. The company filed for Chapter 11 bankr...
What is DermTech, Inc.'s Cyborg Score?+
DermTech, Inc. has a Cyborg Score of 1/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are DermTech, Inc.'s main competitors?+
Named competitors include Strata Skin Sciences. The full competitive landscape is in the AskCyborg report.
How can I get the full DermTech, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the DermTech, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track DermTech, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.